Skip to main content
Presentation
View the updated corporate deck and neoadjuvant colon cancer strategy for BOT+BAL

Corporate Presentation

Press & Events

Press Releases

August 6, 2026
2026

Agenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer

Download
July 28, 2026
2026

Agenus to Provide Second Quarter 2026 Financial Report and Development Update

Download
July 17, 2026
2026

Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026

Download
All Press

Upcoming & Recent Events

September 10, 2026 4:30 PM

Agenus Stakeholder Webcast | September 2026

Webcast
2026
Add to calendar
August 6, 2026 7:30 AM

Agenus Q2 2026 Earnings

2026
July 13, 2026 8:30 AM

Agenus PIPE Financing Announcement

2026
Archive Events
Add this event to your calendar

Choose a calendar. You’ll be redirected or an .ics file will be downloaded with the event details pre-filled.

Title:
Agenus Stakeholder Webcast | September 2026
Date:
September 10, 2026
Time:
4:30 pm
Location:
Webcast
10.09.2026
G
Google Calendar
Opens Google Calendar in a new tab
O
Outlook Calendar
Opens Outlook Calendar
A
Apple Calendar (.ics)
Downloads an ICS file
Add this event to your calendar

Choose a calendar. You’ll be redirected or an .ics file will be downloaded with the event details pre-filled.

Title:
Agenus Q2 2026 Earnings
Date:
August 6, 2026
Time:
7:30 am
06.08.2026
G
Google Calendar
Opens Google Calendar in a new tab
O
Outlook Calendar
Opens Outlook Calendar
A
Apple Calendar (.ics)
Downloads an ICS file
Add this event to your calendar

Choose a calendar. You’ll be redirected or an .ics file will be downloaded with the event details pre-filled.

Title:
Agenus PIPE Financing Announcement
Date:
July 13, 2026
Time:
8:30 am
Location:
13.07.2026
G
Google Calendar
Opens Google Calendar in a new tab
O
Outlook Calendar
Opens Outlook Calendar
A
Apple Calendar (.ics)
Downloads an ICS file

Investor
Portal

Explore the Agenus investor portal for all information on financials, stock, filings and more.

Visit Investor Portal

Contact Us

Agenus Inc.
investor@agenusbio.com

Quick Links

SEC Filings
Quarterly Results
Annual Reports
Agenus Inc.
3 Forbes Road
Lexington, MA 02421-7305
T: +1 (781) 674 4400 | F: +1 (781) 674 4200
Our Science
Pipeline
Publications
Clinical Trials
Immunotherapy
About BOT + BAL
Company
Our History
Our Team
Careers
Partners
Access
Patient Access
Contact Medical Affairs
Resources
Press Releases
In the News
Patient Resources
FAQs
Investors
Investor Overview
Events
Financial Information
Opt-out preferencesCookie PolicyTerms and Conditions of UsePrivacy PolicyCommunity GuidelinesAccess to Investigational Medicines PolicyReport Adverse EventInvestor Portal
© 2025 Agenus Inc. All rights reserved.